4.7 Article

Echinacoside exerts neuroprotection via suppressing microglial α-synuclein/TLR2/NF-κB/NLRP3 axis in parkinsonian models

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Microglia regulate central nervous system myelin growth and integrity

Niamh B. B. McNamara et al.

Summary: This study reveals the crucial role of resident microglia in maintaining myelin health in the central nervous system. Microglia are involved in regulating myelin growth, preserving myelin integrity, and influencing cognitive function. Disruption of the TGF beta 1-TGF beta R1 axis is implicated in the mechanism underlying the loss of myelin health. The findings suggest that targeting microglia could be a potential therapeutic approach for conditions with dysregulated myelin growth and integrity.

NATURE (2023)

Article Biochemistry & Molecular Biology

Alpha-synuclein/MPP+ mediated activation of NLRP3 inflammasome through microtubule-driven mitochondrial perinuclear transport

Xueping Yang et al.

Summary: This study explores the mechanism of NLRP3 inflammasome activation mediated by alpha-synuclein/MPP+. It demonstrates that alpha-synuclein can prime NLRP3 in BV2 cells and induce mitochondrial damage through the ERK-p67phox-Nox2 axis. The co-treatment of alpha-synuclein/MPP+ disrupts mitochondrial homeostasis, decreases NAD(+) concentration, and causes the accumulation of ac-alpha-tubulin, leading to mitochondrial perinuclear aggregation and the co-localization of NLRP3 and ASC.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Review Biochemistry & Molecular Biology

Biomarker of Neuroinflammation in Parkinson's Disease

Tsai-Wei Liu et al.

Summary: This review summarizes the recent advances in the research on inflammatory biomarkers for Parkinson's disease (PD) detection, as well as monitoring disease progression and treatment response. Neuroinflammation plays a crucial role in the pathogenesis and pathological processes of PD, and various anti-inflammatory medications have demonstrated neuroprotective effects in in vivo or in vitro PD models.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Neurosciences

Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease

Nikhil Panicker et al.

Summary: Parkinson's disease is caused by alpha-synuclein accumulation and death of dopamine neurons in the substantia nigra pars compacta, with NLRP3 inflammasome hyperactivation playing a role in the disease. Loss of parkin activity leads to spontaneous assembly of NLRP3 inflammasome in dopamine neurons, which is further exacerbated by mitochondrial-derived reactive oxygen species. Inhibition of neuronal NLRP3 inflammasome assembly can prevent degeneration of dopamine neurons in PD models.

NEURON (2022)

Article Neurosciences

Preventive effects of a standardized flavonoid extract of safflower in rotenone-induced Parkinson's disease rat model

Nuramatjan Ablat et al.

Summary: This study demonstrates the preventive effect of safflower standardized flavonoid extract (SAFE) on a rotenone-induced Parkinson's disease (PD) rat model. Treatment with SAFE significantly improves body weight loss, behavioral deficits, and survival in the PD rats. Additionally, SAFE modifies the levels of neurotransmitters and the number of neurons in specific brain regions. These findings suggest that SAFE has the potential to be a candidate for PD prevention.

NEUROPHARMACOLOGY (2022)

Review Immunology

Inflammation and immune dysfunction in Parkinson disease

Malu Gamez Tansey et al.

Summary: This review explores the role of an ageing immune system, host genetics, and exposure to environmental stressors in promoting the development of Parkinson's disease. It discusses the presence of neuroinflammation and alterations in immune cell populations as well as the potential contributions of viral or bacterial exposure, pesticides, and gut microbiota to disease pathogenesis.

NATURE REVIEWS IMMUNOLOGY (2022)

Review Clinical Neurology

Challenges in the diagnosis of Parkinson's disease

Eduardo Tolosa et al.

Summary: Parkinson's disease is the second most common neurodegenerative disease, with efforts being made to accurately diagnose and characterize it, including validation of diagnostic criteria and identification of genetic subtypes. Progress in diagnostic biomarkers has opened up possibilities for earlier identification, recognition of diverse subtypes, and development of novel treatments.

LANCET NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease

Chenyu Zhang et al.

Summary: The study demonstrates that celastrol exerts neuroprotective effects in Parkinson's disease by inhibiting NLRP3 inflammasome activation through the Nrf2-NLRP3-caspase-1 pathway, leading to the protection of dopamine neurons, alleviation of neuroinflammation, and improvement in motor deficits. These findings highlight the potential of celastrol as a promising therapeutic agent for Parkinson's disease.

REDOX BIOLOGY (2021)

Review Clinical Neurology

Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease

Md Ezazul Haque et al.

MOVEMENT DISORDERS (2020)

Article Biochemistry & Molecular Biology

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

Eunju Lee et al.

CELL DEATH AND DIFFERENTIATION (2019)

Article Neurosciences

FTY720 Inhibits MPP+-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation

Shu Yao et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease

Adelin Gustot et al.

BIOCHEMICAL JOURNAL (2015)

Article Biochemistry & Molecular Biology

Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome

Yiqing Yan et al.

Review Immunology

Systemic inflammation and microglial activation: systematic review of animal experiments

Inge C. M. Hoogland et al.

JOURNAL OF NEUROINFLAMMATION (2015)

Article Multidisciplinary Sciences

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

Stanley B. Prusiner et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Immunology

Innate immune activation in neurodegenerative disease

Michael T. Heneka et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Review Chemistry, Multidisciplinary

GROMACS: Fast, flexible, and free

D Van der Spoel et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)